Pharma News

Plants makes a Mutual Relationship With Good Microbes

  • Posted on: 25 July 2015
  • By: Shalini.Sharma

In normal plants, a defense hormone that keeps bad bacteria out from the surface as well as inside the plant's roots and actively recruits the good ones has been detected by researchers. For the study, the researcher team introduced 38 strains of bacteria that they had isolated from roots grown in the wild soil into a sterile clay. The researchers showed that when they grew plants in that synthetic soil, the presence of salicylic acid determined which microbes colonized the roots. The findings are published in the Science Express.

IOL Chemicals to launch APIs in US market

  • Posted on: 25 July 2015
  • By: Shalini.Sharma

IOL Chemicals and Pharmaceuticals  has received US FDA approval for marketing APIs in US after successful inspection of its ibuprofen manufacturing facility situated at Barnala in Punjab. The said facility at Barnala has also been approved by ANVISA Brazil, WHO and MOH Japan. These approvals will help to build and sustaining the growth by its API business in coming years.

Killer Sea Snail Venom may yield new cancer drug

  • Posted on: 25 July 2015
  • By: PharmaTutor News

Scientists have discovered thousands of toxins hidden deep within the venom of a sea cone snail in Queensland, which may help develop new drugs to treat pain, cancer and other diseases. Researchers used biochemical and bioinformatics tools to develop a new method to analyse the structure of the venom toxins, allowing them to delve deeper than ever before.

GSK's Mosquirix™ receives positive opinion from European regulators for the prevention of malaria

  • Posted on: 24 July 2015
  • By: PharmaTutor News

GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM, also known as RTS,S, in children aged 6 weeks to 17 months. Following this decision, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunisation programmes once approved by national regulatory authorities.

Trivitron Healthcare launch new tests in newborn screening kit

  • Posted on: 24 July 2015
  • By: Shalini.Sharma

Trivitron Healthcare has added two new products in the newborn screening kit for India. The two new tests are Neonatal IRT and Neonatal Toxoplasma gondii IgM that detect disorders which may harm the newborn in later stages of life. Neonatal IRT can detect disorders affecting the lungs, pancreas, intestine and liver. Whereas, Neonatal Toxoplasma gondii IgM can detect neurological and visual disabilities.

Researchers develop brain implant to Deliver Drugs to the Brain via Remote Control

  • Posted on: 24 July 2015
  • By: Shalini.Sharma

Researchers develop a tiny wireless device that, once implanted in the brain, can be activated by remote control to deliver targeted drugs. Size of device is of the width of a human hair. It may be used to treat pain, depression, epilepsy and other neurological disorders in people by targeting therapies to specific brain areas. The researchers believe that similar, more flexible devices could have applications in other areas of the body too, including peripheral organs. The study is published in the Cell.

Novartis antimalarial medicine receives WHO prequalification

  • Posted on: 24 July 2015
  • By: Shalini.Sharma

Novartis, the world's second largest pharmaceutical company, has announced that its antimalarial medicine Coartem 80/480mg received World Health Organisation (WHO) prequalification, making it the first and only high strength (80/480mg) artemisinin-based combination therapy (ACT) antimalarial treatment available for public sector procurement. This new dosage strength has the potential to improve malaria management.

Pages